Biocon Limited: Certificate Under SEBI (Depositories and Participants) Regulations, 2018 for Q4 FY26
Biocon Limited has submitted a certificate for the quarter ended March 31, 2026, as per SEBI (Depositories and Participants) Regulations, 2018. The company's Registrar and Share Transfer Agent, KFin Technologies Limited, confirmed processing of dematerialization requests within the stipulated timeframe.
This is a standard compliance filing as required by SEBI regulations and is part of the regular reporting cycle. It does not contain any new material information that would significantly affect the company's operations or valuation.
The announcement is a routine regulatory filing related to share dematerialization and does not contain any significant financial or business updates that would impact the company's stock price.
Biocon Limited has submitted a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2026. This certificate confirms the details of securities dematerialized and/or rematerialized during the said period.
The company has furnished this information to all the stock exchanges where its shares are listed. The enclosed certificate from M/s. KFin Technologies Limited, the Registrar and Share Transfer Agent of Biocon Limited, dated April 04, 2026, provides the confirmation. KFin Technologies Limited has confirmed that during the period from January 1, 2026, to March 31, 2026, they have processed dematerialization requests within 15 days of receipt. This includes confirming and approving demat requests, verifying that securities are listed on stock exchanges, mutilating and cancelling old certificates, and updating the register of members with the depositories as the registered owner.
The announcement was broadcast on April 07, 2026.
What to do with a filing like this
Biocon Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Biocon Limited. Read the original for the full detail.